GalNAc CPG allows the synthesis of siRNA-GalNAc conjugate.

500Å and 1000Å are available.

The price is on request.

N-acetylgalactosamine (GalNAc) is a well-defined liver-targeted moiety benefiting from its high affinity with asialoglycoprotein receptor (ASGPR).

By conjugating it directly to the oligonucleotides or decorating it to a certain delivery system as a targeting moiety, GalNAc has achieved compelling successes in the development of nucleic acid therapeutics. 

Other reagents for GalNAc conjugate technology are available under request.